REG - Dr. Martens PLC - CFO start date - update

Dr MartensAnnouncement

10/05/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240510:nRSJ8078Na&default-theme=true

RNS Number : 8078N  Dr. Martens PLC  10 May 2024

 

10 May 2024

Dr. Martens plc

 

CFO start date - update

 

Dr. Martens plc updates that Giles Wilson, who has been appointed to the role
of Chief Financial Officer (CFO), will join the business and the Board on
13(th) May 2024, two weeks earlier than the previously announced date of
27(th) May 2024.

 

 

 

Enquiries

Investors and analysts

Bethany Barnes, Director of Investor Relations
Bethany.Barnes@drmartens.com    +44 7825 187465

Beth Callum, Investor Relations Manager
Beth.Callum@drmartens.com  +44 203 995 2644

 

Press
 

H/Advisors Maitland
                                +44 207 379 5151

   Katharine Spence
                                +44 7384 535739

 

Gill Hammond, Director of Communications
                                +44 7384 214248

 

 

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DM's"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude. The Company is a constituent of the FTSE
250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPEANSNELNLEEA